Comparison of Volinanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties

NCT00788515 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
33
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor's decision due to absence of demonstration of efficacy of volinanserin in primary insomnia with predominant sleep maintenance problems

Conditions

Interventions

Sponsor

Sanofi